Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings: March 1-2, 2024, Abu Dhabi, United Arab Emirates.

Author unknown

Open source

DOI
10.36401/jipo-24-x2
Published
2024 Aug
Container
Journal of immunotherapy and precision oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36401/jipo-24-x2,
  title = {Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings: March 1-2, 2024, Abu Dhabi, United Arab Emirates.},
  year = {2024},
  journal = {Journal of immunotherapy and precision oncology},
  doi = {10.36401/jipo-24-x2},
  url = {https://doi.org/10.36401/jipo-24-x2}
}

RIS

TY  - JOUR
TI  - Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings: March 1-2, 2024, Abu Dhabi, United Arab Emirates.
PY  - 2024
JO  - Journal of immunotherapy and precision oncology
DO  - 10.36401/jipo-24-x2
UR  - https://doi.org/10.36401/jipo-24-x2
ER  - 

APA

Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings: March 1-2, 2024, Abu Dhabi, United Arab Emirates.. (2024). Journal of immunotherapy and precision oncology. https://doi.org/10.36401/jipo-24-x2

Source records